No abstract

The goal of programmes to provide contraception for elephants should be to formulate an approach that does not require the relocation or immobilisation of the same individual year after year, which would be long-lasting and cause minimal disruption to social and reproductive behaviour. The programmes should be simple to administer, safe and cost-effective, and must meet the objectives defined by managers in the field. An immunocontraceptive programme was initiated in a small free-roaming population of elephants at the Greater Makalali Private Game Reserve in Limpopo Province in 2000 to determine whether the porcine zona pellucida (pZP) vaccine can successfully control population sizes. Further objectives were to determine implementation costs and efficiency through a multi-faceted approach. We have demonstrated that immunocontraception meets the objectives set by managers in the field. Minimal social disruption was observed over the course of treatment, with the mode of delivery (ground or aerial vaccinations) determining the degree of stress within herds and speed of resumption of normal movement patterns. Aerial vaccinations resulted in the least disturbance, with target herds being approachable within a day. In 2005, implementation costs were R880-R1000 / elephant / year, inclusive of darts, vaccine, helicopter and veterinary assistance. Irrespective of the source or method of vaccine delivery, a non-pregnant elephant is rendered infertile from 1st vaccine administration. The sooner immunocontraception is implemented, the sooner population growth rates can be controlled. pZP contraception is a realistic alternative management tool, particularly if used as part of a long-termmanagement strategy. Mass-darting from the air eliminates the need for detailed individual histories of each elephant or for employing a person to monitor elephants. Thus, implementation of immunocontraception in larger populations is feasible and practical

Background: The native porcine zona pellucida (pZP) vaccine has been successfully used for immunocontraception of wild horses, white-tailed deer and approximately 90 zoo species for more than 25 years.Objectives: To provide proof of concept and test contraceptive efficacy of pZP in African elephants. Once completed, test the population and behavioural effects on cows in the Greater Makalali Private Game Reserve (GMPGR). Following the GMPGR, test efficacy, population effects, safety and reversibility in 25 reserves with populations ranging from 9 to 700 elephants.Method: Histological sections were reacted with anti-pZP antibodies to provide proof of concept. From 1996 to 2000, 21 and 10 cows were treated with pZP vaccine in the Kruger National Park (KNP) and monitored for pregnancy. Population effects of pZP with Freund’s adjuvants (three vaccinations in Year 1 with one annual booster) were studied on 18 cows in the GMPGR. Another six game reserves with a total of 90 cows were added to the project. The project was then expanded to include another 18 reserves.Results: Binding of anti-pZP antibodies to elephant zona proteins was demonstrated in vitro. The KNP provided efficacy results of 56% and 80%, respectively. The contraceptive efficacy in the GMPGR and additional six reserves was 100% following calving of pregnant cows. Safety and lack of impact on social behaviour were demonstrated. In larger populations, efficacy was 95%.Conclusion: Contraceptive efficacy and safety of pZP vaccine could be demonstrated in small to large populations. The methodology is now being implemented in approximately 800 cows on 26 reserves across South Arica.

No abstract

Globally, African savanna elephants have been assessed as ‘endangered’. Consequently, additional threats and losses due to human–elephant conflict (HEC) could further exacerbate the species’ decline. In stark contrast, South Africa’s elephant populations are mostly confined within fenced-in reserves that impede natural processes such as migration. As ecosystem engineers, elephant population growth herein should be limited. Within South Africa, elephant management has evolved as differing wildlife philosophies from utilitarian conservation (‘nature for man’) to biocentric preservation (‘nature for nature’) and a combination thereof, have been practiced. Traditionally, both HEC and population control have been largely synonymous with lethal control, i.e. culling. However, with the increase of public or expert input to Policy, lethal control is not favoured by the public. As an alternative, immunocontraception of female African savanna elephants through non-invasive, native porcine zona pellucida (pZP) vaccinations has been employed successfully and is currently adopted in 43 elephant reserves across South Africa. Current legislation now recommends culling as the last population management resort. Newly promulgated legislation calls for wellbeing and welfare to be carefully measured in all biodiversity management decisions taken to minimise threats to biodiversity. As a keystone species, elephant is a direct driver of biodiversity change. Accordingly, and in light of these developments, all population management options, including immunocontraception, must be fully considered in South Africa’s largest national park, the Kruger.